Q1 FY27: Revenue up 187% YoY to Rs 489.66 Cr; PAT surges to Rs 18.63 Cr
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.7 pts more than Nifty Microcap 250 and 5.8 pts more than its Animal Feed peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mukka Proteins Q1 FY27 consolidated revenue up 187% YoY at Rs 4,896.54 million vs Rs 1,707.74 million. PAT at Rs 186.34 million vs Rs 15.89 million. Standalone revenue Rs 4,058.56 million, PAT Rs 194.07 million. Board cancelled Rs 75 crore NCD private placement. Approved 25.98% stake in Swachha Eco Solutions for Rs 64.92 lakh as associate. Re-appointed 3 independent directors and MD/CEO, CFO, COO for 5 years. 16th AGM on September 10, 2026.
Strong Q1 with revenue and PAT up sharply YoY. NCD cancellation may lower interest burden. New waste management associate diversifies business.